Oragenics inc (OGEN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue, net

-

-

-

0

0

939

-

-

-

-

Revenue, net

-

-

-

-

-

-

1,032

1,331

1,444

1,308

Cost of revenue

-

-

-

0

0

369

343

878

713

911

Gross profit

-

-

-

0

0

570

688

453

-

-

Operating expenses:
Research and development

12,120

5,971

3,539

4,754

8,733

3,065

9,358

7,860

2,449

2,014

General and administrative

3,757

4,022

3,178

3,787

3,047

-

-

-

-

-

Selling, general and administrative

-

-

-

-

-

3,321

7,540

5,024

5,628

6,285

Total operating expenses

15,877

9,994

6,718

8,542

11,780

6,386

16,899

12,885

8,077

8,299

Loss from operations

-15,877

-9,994

-6,718

-8,542

-11,780

-5,816

-16,210

-12,432

-7,346

-7,902

Other income (expense):
Interest income

320

86

10

40

21

36

23

15

1

3

Interest expense

7

5

-

-

-

-

-

-

-

-

Interest expense

-

-

216

4

76

4

17

655

332

33

Local business tax

1

1

3

-

-

-

-

-

-

-

Loss from abandoned public offering

-

-

-

-

-

-

-

-

-

603

Local business tax

-

-

-

4

4

5

9

17

1

2

Changes in derivative liability

-

-

188

-

-

-

-

-

-

-

Other income

0

0

7

14

0

-0

144

-

-

-635

Total other income, net

311

79

-13

45

-59

26

141

-658

-332

-

Loss before income taxes

-15,566

-9,914

-6,731

-8,497

-11,840

-5,789

-16,068

-13,090

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-7,678

-8,538

Income tax benefit

-

-

0

0

0

0

0

0

0

-733

Net loss

-15,566

-9,914

-6,731

-7,013

-11,711

-5,789

-16,068

-13,090

-7,678

-7,805

Deemed dividend of Series D preferred stock

-

1,412

-

-

-

-

-

-

-

-

Net loss applicable to common shareholders

-15,566

-11,326

-6,731

-

-

-

-

-

-

-

Basic and diluted net loss per share

-0.37

-0.87

-1.37

-1.57

-0.32

-0.16

-0.56

-0.74

-1.34

-1.42

Profit from operations of discontinued component

-

-

-

30

128

-

-

-

-

-

Gain on sale of discontinued operations

-

-

-

1,453

-

-

-

-

-

-

Income tax benefit

-

-

-

0

0

-

-

-

-

-

Profit from discontinued operations

-

-

-

1,484

128

-

-

-

-

-

Basic and diluted net profit per share from discontinued operations

-

-

-

0.33

0.00

-

-

-

-

-

Shares used to compute basic and diluted net loss per share

42,283

13,039

4,926

4,460

36,656

36,153

28,779

17,735

5,717

-

Net loss from continuing operations

-

-

-

-8,497

-11,840

-

-

-

-

-

Basic and diluted net loss per share from continuing operations

-

-

-

-1.90

-0.32

-

-

-

-

-

Shares used to compute basic and diluted net loss per share

42,283

13,039

4,926

4,460

36,656

36,153

28,779

17,735

5,717

-

Shares used to compute basic and diluted net loss per share

42,283

13,039

4,926

4,460

36,656

36,153

28,779

17,735

5,717

-

Shares used to compute basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

5,511